Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa.

INTRODUCTION

The aim of this study was to assess age- and gender-specific incidence rates (IRs) of acetylcholine receptor (AChR)-antibody-positive myasthenia gravis (MG) in South Africa, and geographical variations in incidence.

METHODS

IRs were calculated from positive AChR-antibody laboratory data between 2011 and 2012, using 2011 population census data.

RESULTS

890 individuals were seropositive, for an annual IR of 8.5 per million. Age-standardized IR for early-onset (<50) and late-onset (≥50) MG were 4.1 and 24 per million, respectively, and 4.3 per million for juveniles. The IR between provinces ranged from 1 to 19 per million.

CONCLUSIONS

In this Southern Hemisphere African population, the overall IR and peak IR (in older men) for seropositive MG is comparable to that in Europe and North America, arguing against environmental factors. However, IRs may be higher among children with African genetic ancestry. Geographical variation in incidence underscores the importance of outreach programs for regions with limited resources.